Investing.com -- Ekso Bionics Holdings Inc (NASDAQ:EKSO) stock surged 20% after the company announced it has secured an agreement to become the exclusive U.S. distributor of MediTouch’s BalanceTutor rehabilitation system.
The exoskeleton technology company, which specializes in medical and industrial applications, will serve as the authorized sales agent for the advanced balance rehabilitation system throughout the United States. The BalanceTutor is described as the only known rehabilitation system featuring a patented 4D perturbation treadmill with multiple force and movement sensors.
According to the announcement, the BalanceTutor’s treadmill can move in multiple directions to simulate slips, trips, or stumbles while patients are standing or walking. The system includes an overhead support frame designed to allow patients to safely practice responding to balance disturbances without risking falls.
"We are excited to add MediTouch’s BalanceTutor rehabilitation system to our leading technology offerings, expanding our reach in patient care," said Ekso Bionics’ Chief Executive Officer, Scott Davis. He noted that the technology is "synergistic" with the company’s current go-to-market strategy by targeting the same customer base with complementary technology.
Moshe Druker, VP of Global Business Development at MediTouch, expressed enthusiasm about the partnership, stating it would help expand access to their rehabilitation technology across the U.S. market.
The agreement represents a significant development for Ekso Bionics, which currently has a market capitalization of approximately $11.5 million.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.
